Table 2.
Association between demographics, clinical data, laboratory test data, and primary outcomes.
| Discharge status | p value | Odds ratio (OR, 95% CI, p value) | ||
|---|---|---|---|---|
| Cured 67 (42%) | Died 93 (58%) | |||
| Age (years) | ||||
| 20–59 | 58 (55%) | 48 (45%) | <0.001 | 0.17, 0.074–0.373, <0.001 |
| ≥60 | 9 (17%) | 45 (83%) | ||
|
| ||||
| Sex | ||||
| Female | 10 (25%) | 30 (75%) | 0.012 | 2.7, 1.22–6.04, 0.015 |
| Male | 57 (47.5%) | 63 (52.5%) | ||
|
| ||||
| Diabetes | ||||
| Yes | 20 (38.5%) | 32 (61.5%) | 0.544 | — |
| No | 47 (43.5%) | 61 (56.5%) | ||
|
| ||||
| Renal failure | ||||
| Yes | 1 (20%) | 4 (80%) | 0.400 | — |
| No | 66 (43%) | 89 (57%) | ||
|
| ||||
| Pulmonary disease | ||||
| Yes | 23 (29.5%) | 55 (70.5%) | 0.002 | 2.8, 1.44–5.32, 0.002 |
| No | 44 (54%) | 38 (46%) | ||
|
| ||||
| Heart disease | ||||
| Yes | 21 (49%) | 22 (51%) | 0.291 | — |
| No | 43 (39%) | 66 (61%) | ||
|
| ||||
| Ferritin | ||||
| Normal | 1 (17%) | 5 (83%) | 0.401 | — |
| Increased | 59 (42%) | 80 (58%) | ||
|
| ||||
| D-dimer | ||||
| Normal | 6 (100%) | 0 (0%) | 0.003 | 21, 1.16–380.47, 0.039 |
| Increased | 50 (38%) | 81 (62%) | ||
|
| ||||
| AST | ||||
| Normal | 33 (66%) | 17 (34%) | <0.001 | 4.17, 2.04–8.5, 0.001 |
| Increased | 34 (32%) | 73 (68%) | ||
|
| ||||
| ALT | ||||
| Normal | 37 (36%) | 66 (64%) | 0.033 | 0.48, 0.24–0.95, 0.034 |
| Increased | 28 (54%) | 24 (46%) | ||
|
| ||||
| ALP | ||||
| Decreased | 58 (40%) | 88 (60%) | — | — |
| Normal | 0 (0%) | 0 (0%) | ||
|
| ||||
| Total protein | ||||
| Decreased | 0 (0%) | 22 (100%) | 0.001 | 26.8, 1.56–462.2, 0.023 |
| Normal | 23 (37%) | 39 (63%) | ||
|
| ||||
| Bilirubin total | ||||
| Normal | 42 (43%) | 55 (57%) | 0.065 | |
| Increased | 8 (25%) | 24 (75%) | ||
|
| ||||
| Bilirubin nonconjugated | ||||
| Normal | 24 (63%) | 14 (37%) | <0.001 | 4.2, 1.86–9.26, 0.0005 |
| Increased | 26 (29%) | 63 (71%) | ||
|
| ||||
| Creatinine | ||||
| Normal | 47 (84%) | 9 (16%) | <0.001 | 27.2, 11.01–66.94, <0.001 |
| Increased | 15 (16%) | 78 (84%) | ||
|
| ||||
| BUN | ||||
| Normal | 41 (87%) | 6 (13%) | <0.001 | 26.4, 9.87–70.37, <0.001 |
| Increased | 21 (21%) | 81 (79%) | ||
|
| ||||
| CRP | ||||
| Normal | 22 (41.5%) | 31 (58.5%) | 0.584 | |
| Increased | 27 (36.5%) | 47 (63.5%) | ||
|
| ||||
| RBCs | ||||
| Decreased | 25 (28%) | 65 (72%) | <0.001 | 4.4, 2.22–8.59, <0.001 |
| Normal | 42 (63%) | 25 (37%) | ||
|
| ||||
| Hb | ||||
| Decreased | 26 (25%) | 77 (75%) | <0.001 | 8.7, 4.09–18.4, <0.001 |
| Normal | 41 (74.5%) | 14 (25.5%) | ||
|
| ||||
| Neutrophils | ||||
| Normal | 33 (80.5%) | 8 (19.5%) | <0.001 | 6.7, 2.7–16.48, <0.001 |
| Increased | 22 (22%) | 80 (78%) | ||
|
| ||||
| Eosinophils | ||||
| Decreased | 23 (26%) | 66 (74%) | <0.001 | 4.2, 2.03–8.58, 0.001 |
| Normal | 32 (59%) | 22 (41%) | ||
|
| ||||
| Basophils | ||||
| Decreased | 31 (29.5%) | 74 (70.5%) | <0.001 | 4.1, 1.87–8.94, 0.0004 |
| Increased | 24 (63%) | 14 (37%) | ||
|
| ||||
| Monocytes | ||||
| Decreased | 7 (20%) | 28 (80%) | 0.01 | 3.2, 1.29–7.96, 0.0123 |
| Normal | 48 (44%) | 60 (56%) | ||
|
| ||||
| Lymphocytes | ||||
| Decreased | 35 (29%) | 84 (71%) | <0.001 | 12, 3.82–37.66, <0.001 |
| Normal | 20 (83%) | 4 (17%) | ||
BUN: blood urea nitrogen; CRP: C-reactive protein; Hb: hemoglobin; AST: aspartate aminotransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase. Symbol “—” indicates value that cannot be calculated due to zero cases/not significant value or incalculable odd ratio.